title: Systematic review and meta-analysis of the influence of HER2 expression and amplification in operable oesophageal cancer.
abstract: BACKGROUND
  The prognostic significance of human epidermal growth factor 2 (HER2) overexpression in patients diagnosed with oesophageal cancer is controversial. We performed a systematic review and meta-analysis to determine the influence of HER2 overexpression and amplification on outcomes in operable oesophageal cancer.
  
  
  METHODS
  MEDLINE and Embase (January 1990 to November 2011) was searched for translational studies that correlated HER2 expression with survival in operable oesophageal cancer.
  
  
  RESULTS
  Fourteen studies involving 1,464 patients who had undergone potentially curative oesophagectomy for oesophageal cancer [322 (22%) HER2-positive] were included. Five-year mortality was significantly higher in HER2-positive patients [odds ratio (OR) 1.43, 95% confidence interval (CI) 1.04 to 1.95, p = 0.03]. Analysis related to histological cell type demonstrated significantly higher 5-year mortality in HER2-positive squamous cell carcinoma [OR 2.88, 95% CI 1.34 to 6.17, p = 0.006] and adenocarcinoma [OR 1.91, 95% CI 1.15 to 3.17, p = 0.01] on sensitivity analysis of higher-quality studies.
  
  
  CONCLUSIONS
  HER2 overexpression and gene amplification in operable oesophageal cancer was an indicator of poor prognosis.
authors: University Hospital of Wales, Heath Park, Cardiff, Wales, CF14 4XN, UK. dcsy23@gmail.com
authors: David S Y
authors: DS
authors: Chan
authors: Christopher P
authors: CP
authors: Twine
authors: Wyn G
authors: WG
authors: Lewis
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000401:mortality / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000401:mortality / Q000601:surgery; D004938:Esophageal Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000601:surgery; D016629:Esophagectomy; D005784:Gene Amplification; D018734:Genes, erbB-2; D005819:Genetic Markers; D006801:Humans; D016017:Odds Ratio; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000378:metabolism*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D005819:Genetic Markers; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human